ARTICLE | Company News
Wyeth neurology news
March 9, 2009 7:00 AM UTC
The U.S. Supreme Court ruled 6-3 that an FDA-approved label for Phenergan promethazine from Wyeth did not preempt state tort law in a product liability suit. In Wyeth v. Levine, the majority conclu...